GENENTECH GROWTH HORMONE SALES FORCE RETRAINING TO BEGIN IN 1997 AS PART OF CORRECTION ACTION PROGRAM STEMMING FROM AD DIVISION LETTER ON PROTROPIN

Genentech will retrain its sales force beginning in 1997 as part of a corrective campaign agreed upon by the company and FDA following a December 1995 letter from the Division of Drug Marketing, Advertising, and Communications concerning Genentech's promotion of Protropin (somatrem for injection).